ConductScience.org, home

Paper36364402

1,4-Naphthoquinone Motif in the Synthesis of New Thiopyrano[2,3-d]thiazoles as Potential Biologically Active Compounds.

Lozynskyi A and 15 others. Molecules, 2022. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. 1,4-Naphthoquinone Motif in the Synthesis of New Thiopyrano[2,3-d]thiazoles as Potential Biologically Active Compounds. Papers, record 36364402. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36364402

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
1,4-Naphthoquinone Motif in the Synthesis of New Thiopyrano[2,3-d]thiazoles as Potential Biologically Active Compounds.
PubMed
Journal
Molecules
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.89
iCite
Revised in PubMed
2022-11-17
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lozynskyi AAndrii
2Senkiv JJulia
3Ivasechko IIryna
4Finiuk NNataliyahttps://orcid.org/0000-0002-4112-8815
5Klyuchivska OOlgahttps://orcid.org/0000-0001-8657-5945
6Kashchak NNataliya
7Lesyk DDanylo
8Karkhut AAndriy
9Polovkovych SSvyatoslavhttps://orcid.org/0000-0002-7143-6931
10Levytska OOksana
11Karpenko OOlexandr
12Boshkayeva AAssyl
13Sayakova GGaliya
14Gzella AAndrzej
15Stoika RRostyslav
16Lesyk RRomanhttps://orcid.org/0000-0002-3322-0080

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NaphthoquinonesMajor topic
Antineoplastic AgentsMajor topic
Thiazoles
Tumor Suppressor Protein p53
Drug Screening Assays, Antitumor

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
0121U100690Ministry of Health of UkrainePubMed
2020.02/0035National Research Foundation of UkrainePubMed

Source PubMed

Download CSV of grants

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126133066Synthesis and anticancer activity of some new thiopyrano[2,3-d]thiazoles incorporating pyrazole moiety.Chem Pharm Bull (Tokyo)2015https://conductscience.org/library/papers/26133066PubMed
229358624Long-acting injectable atovaquone nanomedicines for malaria prophylaxis.Nat Commun2018https://conductscience.org/library/papers/29358624PubMed
330791399Vitamin K: Double Bonds beyond Coagulation Insights into Differences between Vitamin K1 and K2 in Health and Disease.Int J Mol Sci2019https://conductscience.org/library/papers/30791399PubMed
410891138Studies of Diastereoselectivity in Diels-Alder Reactions of Enantiopure (SS)-2-(p-Tolylsulfinyl)-1,4-naphthoquinone and Chiral Racemic Acyclic Dienes.J Org Chem2000https://conductscience.org/library/papers/10891138PubMed
57816645A rapid and simple method for the isolation of apoptotic DNA fragments.Nucleic Acids Res1994https://conductscience.org/library/papers/7816645PubMed
616469140Menadione is a metabolite of oral vitamin K.Br J Nutr2006https://conductscience.org/library/papers/16469140PubMed
7105495802- or 6-(1-azidoalkyl)-5,8-dimethoxy-1,4-naphthoquinone: synthesis, evaluation of cytotoxic activity, antitumor activity and inhibitory effect on DNA topoisomerase-I.Arch Pharm Res1999https://conductscience.org/library/papers/10549580PubMed
835533562Novel hybrid pyrrolidinedione-thiazolidinones as potential anticancer agents: Synthesis and biological evaluation.Eur J Med Chem2022https://conductscience.org/library/papers/35533562PubMed
919171970Structure validation in chemical crystallography.Acta Crystallogr D Biol Crystallogr2009https://conductscience.org/library/papers/19171970PubMed
1023833711Synthesis and Biological Activity of New Thiopyrano[2,3-d]thiazoles Containing a Naphthoquinone Moiety.Sci Pharm2013https://conductscience.org/library/papers/23833711PubMed
1119505805Diospyrone, crassiflorone and plumbagin: three antimycobacterial and antigonorrhoeal naphthoquinones from two Diospyros spp.Int J Antimicrob Agents2009https://conductscience.org/library/papers/19505805PubMed
1219924086The trypanocidal activity of naphthoquinones: a review.Molecules2009https://conductscience.org/library/papers/19924086PubMed
1334771471New Therapeutic Strategy for Overcoming Multidrug Resistance in Cancer Cells with Pyrazolo[3,4-d]pyrimidine Tyrosine Kinase Inhibitors.Cancers (Basel)2021https://conductscience.org/library/papers/34771471PubMed
14294611851,4-Naphthoquinone derivatives potently suppress Candida albicans growth, inhibit formation of hyphae and show no toxicity toward zebrafish embryos.J Med Microbiol2018https://conductscience.org/library/papers/29461185PubMed
157785975Effect of atovaquone and atovaquone drug combinations on prophylaxis of Pneumocystis carinii pneumonia in SCID mice.Antimicrob Agents Chemother1995https://conductscience.org/library/papers/7785975PubMed
16246663032-Chloro-1,4-naphthoquinone derivative of quercetin as an inhibitor of aldose reductase and anti-inflammatory agent.J Enzyme Inhib Med Chem2015https://conductscience.org/library/papers/24666303PubMed
1731231607p53-Dependent Anti-Proliferative and Pro-Apoptotic Effects of a Gold(I) N-Heterocyclic Carbene (NHC) Complex in Colorectal Cancer Cells.Front Oncol2019https://conductscience.org/library/papers/31231607PubMed
1823275348The naphthoquinone diospyrin is an inhibitor of DNA gyrase with a novel mechanism of action.J Biol Chem2013https://conductscience.org/library/papers/23275348PubMed
1919559098A novel and simple method of screening compounds for interaction with DNA: A validation study.Mutat Res2009https://conductscience.org/library/papers/19559098PubMed
208416812Methyl green. A DNA major-groove binding drug.FEBS Lett1993https://conductscience.org/library/papers/8416812PubMed

See all 47 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
41471376Molecular Hybridization of Naphthoquinones and Thiazoles: A Promising Strategy for Anticancer Drug Discovery.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41471376PubMed
39620933Characterization of naphthoquinones as inhibitors of glutathione reductase and inducers of intracellular oxidative stress.Redox Rep2024https://conductscience.org/library/papers/39620933PubMed
392979234-Methylthiazole triggers apoptosis and mitochondrial disruption in HL-60 cells.Mol Biol Rep2024https://conductscience.org/library/papers/39297923PubMed

Download CSV of cited by

Genes11

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36364402

GET https://conductscience.org/api/papers/v1/36364402/references?page=2